McKinsey & Company to pay $650 million for role in opioid crisis
McKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.
McKinsey nears $600m settlement with US government over role in opioid crisis
McKinsey is nearing a settlement over its role in the opioid crisis, negotiating a deferred prosecution agreement with a payout exceeding $600 million.
McKinsey agrees to pay $122 million to settle South African bribery charges in the US
McKinsey agrees to pay over $122 million to settle bribery claims related to its operations in South Africa.
McKinsey & Company to pay $650 million for role in opioid crisis
McKinsey and Company agreed to pay $650 million to settle charges over its role in promoting OxyContin amid rising opioid crises.
McKinsey nears $600m settlement with US government over role in opioid crisis
McKinsey is nearing a settlement over its role in the opioid crisis, negotiating a deferred prosecution agreement with a payout exceeding $600 million.
McKinsey agrees to pay $122 million to settle South African bribery charges in the US
McKinsey agrees to pay over $122 million to settle bribery claims related to its operations in South Africa.